Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

2025 Event

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

TripleBlind https://www.tripleblind.ai unlocks the estimated 105 petabytes of data stored by enterprises today that are inaccessible and not commercialized due to privacy concerns, operational complexity and regulation. 

The company’s patented breakthroughs in advanced mathematics enable organizations to privately share larger and more diverse data sets. Many high-value applications apply, such as  innovating enhanced algorithms for medical diagnoses and improving anti-fraud initiatives for financial services. TripleBlind is the only technology that enables enterprises to rapidly commercialize data while maintaining compute performance; enabling all types of analysis on all data types, such as PII, PHI, genomic data, images, and confidential financial records. At the same time, the solution automatically enforces all international and regional data privacy standards including HIPAA, GDPR, PDPR and CCPA.

TripleBlind is superior to existing solutions such as homomorphic encryption (slows compute performance), secure enclaves (siloes data), tokenization/masking/hashing and differential privacy (reduces accuracy), synthetic data (not real data), federated learning (limited use for algorithms), confidential computing (requires data centralization) and blockchain (not interoperable). Innovators such as Accenture, the Mayo Clinic and Snowflake trust TripleBlind to protect sensitive data. Please contact us for an overview, live demo or a one-hour, hands-on workshop.

TripleBlind - HLTH 2021 Sponsor

TrialCard has been offering strategic guidance and integrated solutions to the biopharmaceutical marketplace for over 20 years.  We provide clients with affordability and adherence solutions, including reimbursement and access support, pharmacy and medical benefit co-pay assistance, free trial, and patient assistance programs. TrialCard also offers integrated hub solutions, payer policy intelligence, a non-commercial dispensing pharmacy, and tele-detailing and tele-promotion services. Our attention to detail and locations in areas rich in healthcare talent enable us to provide a level of service that is unsurpassed in our industry.  Founded in 2000, the company is headquartered in Morrisville, NC.

TrialCard - HLTH 2021 Sponsor

TripleTree and TT Capital Partners are investment banking and principal investing partners whose broad horizons create opportunities that fuel growth. Our healthcare experience, reputation as a thought leader and expansive network enable us to deliver uncommon clarity in the changing healthcare industry.TripleTree has been enhancing and advancing the short and long-term positions of innovative and high-growth healthcare technology and services businesses since 1997, acting as a strategic and financial advisor and providing sell-side and buy-side M&amp;A services.TT Capital Partners is a source of capital and expertise for growth-stage healthcare technology and services companies on a structured path to disrupt and innovate the ways in which healthcare is delivered, managed and consumed.

Triple Tree - HLTH 2021 Sponsor